Preliminary Data On A Phase 1b, First-In-Human Study Of The Allosteric Extracellular Fgfr2 Inhibitor Alofanib In Patients With Refractory Metastatic Gastric Cancer.
CANCER RESEARCH(2021)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined